JNJ
WAITJohnson & Johnson
$256.35
+0.21%delayed
News – · Trend ▼ · inside triggers –
Expected move (1d)
▼ $249.95to$262.75 ▲
ATR ±$6.40 (+2.50%)Implied ±$6.37 (+2.48%)
Entry Reference
Price / prev close$256.35 / $255.82
Day range$253.29 – $258.47
52-wk range$166.64 – $274.90(83%)
Volume vs avg0.55×
ATR (14d)$6.40
MA 8 / 21$261.09 / $258.04
MA 50 / 200$245.20 / $226.43
Call ▲ / Put ▼ trigger$257.33 / $254.31
+1 / +2 ATR$262.75 / $269.16
-1 / -2 ATR$249.95 / $243.54
Support: 251.71 247.21 245.49
Resistance: 269.43
Near-the-money contracts
exp 2026-08-07Calls
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 250 | $7.75 | 38% | 0.72 | -0.38 | 47 |
| 252.5 | $5.90 | 33% | 0.66 | -0.36 | 20 |
| 255 | $3.83 | 26% | 0.58 | -0.31 | 946 |
| 257.5 | $2.83 | 26% | 0.46 | -0.31 | 1459 |
| 260 | $2.00 | 27% | 0.35 | -0.30 | 534 |
| 262.5 | $1.23 | 26% | 0.24 | -0.24 | 59 |
Puts
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 250 | $1.09 | 25% | -0.20 | -0.19 | 572 |
| 252.5 | $1.82 | 27% | -0.31 | -0.26 | 52 |
| 255 | $2.67 | 26% | -0.42 | -0.27 | 1521 |
| 257.5 | $3.54 | 25% | -0.54 | -0.27 | 87 |
| 260 | $5.47 | 26% | -0.66 | -0.25 | 271 |
| 262.5 | $6.80 | 30% | -0.73 | -0.25 | 19 |
Δ = delta (≈ probability ITM), θ/day = daily time decay, IV = implied vol. Greeks computed via Black-Scholes from Yahoo IV.
Recent news
- 3 Dividend Stocks to Buy and Hold Forever3h ago
- Johnson & Johnson (JNJ) Stock Sees Modest Fair Value Lift After Analyst Target Increases11h ago
- J&J’s biotech progress could punish its 2027 profit22h ago
- Abbott Laboratories vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?1d ago
- Johnson & Johnson vs. Danaher: Which Healthcare Stock Looks Better Positioned Following Earnings?1d ago
- Should You Invest in Liquidia Corporation Stock Ahead of Q2 Earnings?1d ago
- These dow jones stocks are moving in today's session1d ago
- ABBV Beats on Q2 Earnings & Sales, Cuts '26 EPS View, Stock Down1d ago
- AbbVie Trims Full-Year Profit Outlook Due to Apogee Acquisition1d ago
- The Signs Before Eli Lilly Stock Surged Were All On The Record1d ago
- Johnson & Johnson Shares Edge Higher as $3.5B Biotech Moves Expand Oncology Pipeline1d ago
- LLY Stock: Collect 12% Now, In Exchange For Capping Upside At 15%1d ago
Reference data only. Not a recommendation. Greeks and expected-move figures are estimates, not certainties. You confirm all entries and contracts in TradingView and Charles Schwab.